Investor Ideas #Potcasts;
#Cannabis News and #Stocks on the Move; (CSE: $BEV.C) (TSX:
$FAF.TO) (OTCQB: $GBLX) (NASDAQ: $NBEV)
Delta, Kelowna, BC, December 20, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/12201BEV-FAF-GBLX-NBEV.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
BevCanna
Enterprises Inc. (CSE:BEV) (OTC :BVNNF) announced today that it has exercised its
option to acquire the right, title and interest to DeeperGreen™, the
proprietary water-soluble cannabinoid powder ingredient developed by partner
Greener Frontiers.
"DeeperGreen
technology expands BevCanna's ability to produce a portfolio of cannabis
infused beverage formats," said Emma Andrews, Chief Commercialization Officer
at BevCanna. "The addition of a water-soluble powder allows us to offer
consumers more variety in methods of consumption, which can now pair with
various consumption occasions. Powdered drink mixes complement our existing
expertise in ready-to-drink products and allow us to expand the innovation
pipeline for our house brands, and with white label partners through contract
manufacturing."
DeeperGreen
converts extracted cannabis into a fast-acting, tasteless, odorless,
water-soluble powdered ingredient, and has been proven to be a stable
ingredient that when tested with cannabinoids, consistently delivers target
concentrations within one batch and from batch-to-batch. Independent laboratory
testing has also confirmed that DeeperGreen precisely infuses granular drink
mixes and ready-to-drink water beverages.
Tests
have confirmed that DeeperGreen, and products infused with DeeperGreen, meet
the criteria to pass the current Cannabis Compliance Regulations set in
California, and will allow for reliable water-soluble infusion manufacturing
processes and dosing confidence for consumers.
On
December 18th, 2019, the Company entered into an amendment agreement to the
Cannabis Beverage Joint Development Agreement dated April 1, 2019 with Greener
Frontiers Corporation and BevCanna US Operating Company Ltd., a wholly-owned
subsidiary of the Company. Pursuant to the Agreement, the Company exercised its
right under the JD Agreement to purchase all of the right, title, and interest
in and to DeeperGreen and certain other intellectual property assets of Greener
Frontiers.
Fire & Flower
Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire
& Flower Inc. today announced that it has begun selling new
"cannabis 2.0" product formats in its retail stores in the province
of Saskatchewan.
The
Company is among the first retailers in Canada to be selling these new product
formats. This has been achieved through a private wholesale model in the
province of Saskatchewan, where the Company's wholly-owned distribution
business, Open Fields Distribution purchases from and negotiates prices
directly with Licensed Producers.
New
product formats in Fire & Flower's assortment will be composed of edibles
including gummies, mints and chocolates; and concentrate vaporizers in both
all-in-one and cartridge formats. Fire & Flower's initial assortment of
cannabis 2.0 products in the province is anticipated to include offerings from
the following Licensed Producers and brands prior to the end of 2019: Aphria,
Aurora, Dosist, Cronos, The Green Organic Dutchman, High Park, Organigram,
Redecan, and Sundial.
"With
Fire & Flower being one of the first retailers in Canada to stock new
cannabis formats, this exemplifies the clear benefits of the private
distribution model including price, access and diversity of product within the
province of Saskatchewan," shared Trevor Fencott, Fire & Flower's
Chief Executive Officer. "We have demonstrated leadership through
establishing Open Fields Distribution which supplies both the Fire & Flower
retail network and external accounts within the province of Saskatchewan. There
is significant demand for these new product formats in the market and we look
forward to bringing these products to our loyal customers."
"Our
team has worked diligently over the last year and we are thrilled to be
launching our Solei, RIFF and Good Supply vaporizers in 510 and all-in-ones at Fire
& Flower stores across the province of Saskatchewan," said Bernie
Yeung, Vice President, Sales & Channel Strategy with Aphria Inc. "We
are confident in our market readiness across the country and look forward to
working closely with our retail partners to ensure we have the right brands and
product offerings for consumers as we strive to combat the illicit
market."
Fire
& Flower will continue to monitor consumer preferences of new product
formats using the Hifyre digital retail and analytics platform to judiciously
manage its product assortment and inventory on-hand.
As
new products, including beverages and topcials, become available, Fire &
Flower expects to include these products in the Company's assortment, thereby
increasing consumer choice of new product formats.
The
Company does not yet have a confirmed date for the release of new cannabis
product formats in provinces where government-owned provincial distributors
control the supply chain.
GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for
their Parkinson's disease formulations from the midterm report for their
preclinical study being performed by Dr. Lee Ellis of the National Research
Council (NRC) in Halifax, Nova Scotia, CANADA. GB Sciences' PD formulations
were able to reduce behavioral changes associated with the loss of
dopamine-producing neurons, which underlies the pathology of Parkinson's
disease in the animal model. Our final phase of testing will study the
mechanism of action for these promising formulations, which could potentially
help patients with this debilitating disease. The combined direct and indirect
costs associated with Parkinson's disease are estimated at $52 billion in the
U.S. alone.
"Several
of GB Sciences' mixtures were effective. In fact, our most effective mixture
was able to 'rescue' the PD-like behavioral changes to the point where the
treated animal's behavior was back to baseline. In addition, our PD formulas
produced negligible side effects, which is equally important," explained
Dr. Andrea Small-Howard, Chief Science Officer and Director of both GB
Sciences, Inc. and GBS Global Biopharma, Inc. "These important preclinical
results will be included as 'proof of concept' in GB Sciences' Investigational
New Drug application with the US FDA in order to enter into our 'First-in-Man'
human clinical trial as early as next year."
Central
to the development of Parkinson's disease is the loss of dopamine-producing
neurons. Reduced dopamine levels in the brain lead to movement disorders. GB
Sciences' PD formulations may be protecting dopamine-producing neurons, or they
may cause the surviving neurons to produce more dopamine to compensate for a
loss in the number of dopamine-producing neurons. The final phase of GB
Sciences' preclinical study will examine these and other possible mechanisms
for their effectiveness.
"These
positive preclinical results suggest that our cannabinoid-containing complex
mixtures may be useful for the treatment of Parkinson's disease
symptomology," said Dr. Michael Farley, President and Director of GBS
Global Biopharma, Inc.. "We look forward to bringing these promising
formulations into human clinical trials as early as 2020."
New Age Beverages
Corporation (NASDAQ: NBEV), the Colorado-based healthy
products company, announced the launch of its hemp portfolio in
Australia and New Zealand.
Under
the umbrella of its Health Sciences Division, NewAge received approval and has
begun selling its premium portfolio of hemp oils, creams and lotions in
Australia and New Zealand. The launch initially features three distinct
products:
- ‘NHANCED Hemp Body Cream in a 120 mL tub
- ‘NHANCED Hemp Roll-On Gel 90 mL roll-on
- ‘NHANCED Hemp Oil containing 30 mL tincture
The
products will be sold immediately through more than 2,000 direct-to-consumer distribution
partners across Australia and New Zealand.
“’NHANCED
Hemp is proving to be one of our most talked about product lines we have
launched,” said Brent Willis, Chief Executive Officer of NewAge. “Receiving
approval and beginning to sell our products in these markets further puts us on
the right path to become a leading player in the hemp/CBD industry in Australia
and New Zealand.”
NewAge’s
research and development teams and scientists worked exhaustively over the past
year to develop the hemp specific formulas that both meet the regulatory
requirements of markets like Australia and New Zealand but also maintained the
efficacy, strength, and benefit of NewAge’s full strength CBD formulas.
“’NHANCED
Hemp products were designed and developed to meet stringent government hemp (cannabis sativa) and cannabidiol (CBD)
regulations for safety, purity and efficacy,” said Laura Kimball, director of
product development. “The hemp in these three products is sourced from
industrial hemp grown in the USA and the mature seed is then carefully
processed to ensure that it is pure and completely free from
tetrahydrocannabinol (THC).”
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment